Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SI-Bone Inc (SIBN)
NASDAQ:SIBN
SI-Bone (SIBN) Stock Price & Analysis
154 Followers
SIBN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.76 - $27.86
Previous Close$13
Volume136.27K
Average Volume (3M)353.00K
Market Cap
$535.66M
Enterprise Value$416.57M
Total Cash (Recent Filing)$157.82M
Total Debt (Recent Filing)$38.73M
Price to Earnings (P/E)―
Beta0.53
Next Earnings
Aug 05, 2024EPS Estimate
-$0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.08
Shares Outstanding41,204,796
10 Day Avg. Volume315,613
30 Day Avg. Volume353,000
Standard Deviation0.15
R-Squared0.19
Alpha-0.00682
Financial Highlights & Ratios
Price to Book (P/B)2.96
Price to Sales (P/S)13.24
Price to Cash Flow (P/CF)-54.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.89
Enterprise Value/Gross Profit3.81
Enterprise Value/Ebitda-15.33
Forecast
1Y Price Target
$25.83Price Target Upside98.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
SI-Bone News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSIBN delivered strong top-line results with year-over-year growth in active surgeons and double-digit procedure growth, reflecting a robust financial performance.
Product LaunchThe full launch of Granite 9.5 is anticipated to boost SIBN's growth in the latter half of the year, showcasing the company's innovative capabilities.
Strategic GrowthSIBN's strategic focus on training interventionalists is expanding patient access and is poised to foster growth within the medical technology industry.
Bears Say
Financial PerformanceGross margin declined to 73.8% from 84.1% due to factors such as an excess inventory reserve charge.
Insurance CoverageCode 27278 is proposed as investigational, which could result in lack of coverage for SIBN's allograft products like INTRA and iFuse-Bone.
Market CompetitionIncreased competition is driving procedural uptake in this call point.
---
Ownership Overview
13.16% Insiders
28.79% Mutual Funds
53.74% Other Institutional Investors
4.31% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SIBN FAQ
What was SI-Bone Inc’s price range in the past 12 months?
SI-Bone Inc lowest stock price was $11.76 and its highest was $27.86 in the past 12 months.
What is SI-Bone Inc’s market cap?
Currently, no data Available
When is SI-Bone Inc’s upcoming earnings report date?
SI-Bone Inc’s upcoming earnings report date is Aug 05, 2024 which is in 33 days.
How were SI-Bone Inc’s earnings last quarter?
SI-Bone Inc released its earnings results on May 06, 2024. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.309 by $0.039.
Is SI-Bone Inc overvalued?
According to Wall Street analysts SI-Bone Inc’s price is currently Undervalued.
Does SI-Bone Inc pay dividends?
SI-Bone Inc does not currently pay dividends.
What is SI-Bone Inc’s EPS estimate?
SI-Bone Inc’s EPS estimate is -$0.27.
How many shares outstanding does SI-Bone Inc have?
SI-Bone Inc has 41,204,796 shares outstanding.
What happened to SI-Bone Inc’s price movement after its last earnings report?
SI-Bone Inc reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.309. Following the earnings report the stock price went up 8.287%.
Which hedge fund is a major shareholder of SI-Bone Inc?
Among the largest hedge funds holding SI-Bone Inc’s share is Royce & Associates LLC. It holds SI-Bone Inc’s shares valued at 2M.
---
SI-Bone Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.83 (98.08% Upside)
$25.83 (98.08% Upside)
Blogger Sentiment
Bullish
SIBN Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 13.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $200.8K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.81%
12-Months-Change
Fundamentals
Return on Equity
-33.23%
Trailing 12-Months
Asset Growth
50.07%
Trailing 12-Months
Company Description
SI-Bone Inc
SI-BONE, Inc. is a medical device company, which engages in the research and development of minimally invasive surgical implant system. Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.
---
SIBN Company Deck
---
SIBN Earnings Call
Q1 2024
0:00 / 0:00
---
SIBN Stock 12 Month Forecast
Average Price Target
$25.83
▲(98.08% Upside)
Technical Analysis
Best Analysts Covering SIBN
1 Year
1 Year Success Rate
6/13 ratings generated profit
1 Year Average Return
+10.63%
reiterated a buy rating 2 months ago
Copying Drew Ranieri's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of +10.63% per trade.
---